Literature DB >> 24980117

Synthesis of α, β-unsaturated carbonyl based compounds as acetylcholinesterase and butyrylcholinesterase inhibitors: characterization, molecular modeling, QSAR studies and effect against amyloid β-induced cytotoxicity.

Syed Nasir Abbas Bukhari1, Ibrahim Jantan2, Vijay H Masand3, Devidas T Mahajan3, Muhammad Sher4, M Naeem-ul-Hassan4, Muhammad Wahab Amjad5.   

Abstract

A series of novel carbonyl compounds was synthesized by a simple, eco-friendly and efficient method. These compounds were screened for anti-oxidant activity, in vitro cytotoxicity and for inhibitory activity for acetylcholinesterase and butyrylcholinesterase. The effect of these compounds against amyloid β-induced cytotoxicity was also investigated. Among them, compound 14 exhibited strong free radical scavenging activity (18.39 μM) while six compounds (1, 3, 4, 13, 14, and 19) were found to be the most protective against Aβ-induced neuronal cell death in PC12 cells. Compounds 4 and 14, containing N-methyl-4-piperidone linker, showed high acetylcholinesterase inhibitory activity as compared to reference drug donepezil. Molecular docking and QSAR (Quantitative Structure-Activity Relationship) studies were also carried out to determine the structural features that are responsible for the acetylcholinesterase and butyrylcholinesterase inhibitory activity.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  4-Piperidone; Alzheimer's disease; Neuroprotection; Oxidative stress; Synthesis

Mesh:

Substances:

Year:  2014        PMID: 24980117     DOI: 10.1016/j.ejmech.2014.06.034

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  8 in total

1.  Design and synthesis of new piperidone grafted acetylcholinesterase inhibitors.

Authors:  Alireza Basiri; Michelle Xiao; Alec McCarthy; Debashis Dutta; Siddappa N Byrareddy; Martin Conda-Sheridan
Journal:  Bioorg Med Chem Lett       Date:  2016-11-24       Impact factor: 2.823

Review 2.  Proteinopathies: Deciphering Physiology and Mechanisms to Develop Effective Therapies for Neurodegenerative Diseases.

Authors:  Gouri Chopra; Shabnam Shabir; Sumaira Yousuf; Simran Kauts; Shahnawaz A Bhat; Ashiq H Mir; Mahendra P Singh
Journal:  Mol Neurobiol       Date:  2022-10-07       Impact factor: 5.682

Review 3.  Curcumin in Health and Diseases: Alzheimer's Disease and Curcumin Analogues, Derivatives, and Hybrids.

Authors:  Eirini Chainoglou; Dimitra Hadjipavlou-Litina
Journal:  Int J Mol Sci       Date:  2020-03-13       Impact factor: 5.923

Review 4.  Immunosuppressive Effects of Natural α,β-Unsaturated Carbonyl-Based Compounds, and Their Analogs and Derivatives, on Immune Cells: A Review.

Authors:  Laiba Arshad; Ibrahim Jantan; Syed Nasir Abbas Bukhari; Md Areeful Haque
Journal:  Front Pharmacol       Date:  2017-01-30       Impact factor: 5.810

5.  Antileishmanial and antitrypanosomal activity of symmetrical dibenzyl-substituted α,β-unsaturated carbonyl-based compounds.

Authors:  Abdulsalam Am Alkhaldi; Harry P de Koning; Syed Nasir Abbas Bukhari
Journal:  Drug Des Devel Ther       Date:  2019-04-24       Impact factor: 4.162

Review 6.  Curcumin's Nanomedicine Formulations for Therapeutic Application in Neurological Diseases.

Authors:  Bahare Salehi; Daniela Calina; Anca Oana Docea; Niranjan Koirala; Sushant Aryal; Domenico Lombardo; Luigi Pasqua; Yasaman Taheri; Carla Marina Salgado Castillo; Miquel Martorell; Natália Martins; Marcello Iriti; Hafiz Ansar Rasul Suleria; Javad Sharifi-Rad
Journal:  J Clin Med       Date:  2020-02-05       Impact factor: 4.241

7.  Combinational therapeutics to combat cancer.

Authors:  Ahmed Al Otaibi; Subuhi Sherwani; Eida Mohammed Alshammari; Salma Ahmed Al-Zahrani; Wahid Ali Khan; Abdulmohsen Khalaf Dhahi Alsukaibi; Sourabh Dwivedi; Shahper Nazeer Khan; Mohd Wajid Ali Khan
Journal:  Bioinformation       Date:  2021-07-31

8.  Synthesis and evaluation of new chalcones and oximes as anticancer agents.

Authors:  Syed Nasir Abbas Bukhari
Journal:  RSC Adv       Date:  2022-04-01       Impact factor: 3.361

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.